265 results
Page 3 of 14
8-K
bztandbd fi5n7zf10b
15 Nov 22
Kineta Announces FDA Acceptance of Investigational New Drug (IND) Application for KVA12123 for the Treatment of Advanced Solid Tumors
4:02pm
8-K
EX-99.1
zuw 6bh2o
15 Nov 22
Kineta Announces FDA Acceptance of Investigational New Drug (IND) Application for KVA12123 for the Treatment of Advanced Solid Tumors
4:02pm
425
rxizz
14 Nov 22
Business combination disclosure
8:50am
8-K
EX-99.2
j9cajm
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
8-K
EX-99.1
sj0t07r tpqh
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
8-K
kinzcm2dt1r
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
424B3
3bksziy9ntumj
10 Nov 22
Prospectus supplement
4:21pm
425
3j4f5bk4
27 Oct 22
Business combination disclosure
7:15am
8-K
s8res cpzfl
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
8-K
EX-99.1
w4sfmenpo7eqjsr
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
425
n0on ejp3okae8y
26 Oct 22
Business combination disclosure
5:17pm
8-K
cpsekkyxf 5nj7a6
26 Oct 22
Regulation FD Disclosure
5:14pm
8-K
EX-99.1
2lio7r0g
26 Oct 22
Regulation FD Disclosure
5:14pm
425
evtiee3np6uhfl mz2au
26 Oct 22
Business combination disclosure
5:10pm
8-K
cfkj3ald
26 Oct 22
Regulation FD Disclosure
5:08pm
8-K
EX-99.1
x2uc z2vsaa835ccei
26 Oct 22
Regulation FD Disclosure
5:08pm